Key facts
- Ilasis’s last known valuation is $13.8M (Jun 2023).
- It has raised $7.6M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Bpifrance, IRDI Capital Investissement, Nouvelle Aquitaine Co-Investissement, Philippe du Mesnil, Région Nouvelle-Aquitaine — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ilasis
- ·The full record, as it builds
Funding rounds
No funding rounds for Ilasis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ilasis
Developer of femtosecond laser systems designed for eye surgeries. The company manufactures laser medical devices for ophthalmology and laser scalpels for cataract surgery based on the concept of frugal innovation, enabling ophthalmologists to get irreproachable cutting services, in less time and at a lower cost.
- Sector
- Healthcare
- HQ
- Pessac, France
- Founded
- 2019
- Employees
- 16
- Website
- helixsurgical.com/
- Ownership
- Privately Held (backing)
Ilasis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ilasis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ilasis in its N-PORT filings yet. We sweep new filings monthly.